SELEX Sequencing Data Analysis

About this service

SELEX (systematic evolution of ligands by exponential enrichment) is a research method for selecting nucleic-acid ligands for a target. Sequencing data may be analyzed to compare sequence enrichment across selection rounds, but read counts alone do not prove binding affinity, clinical biomarker status or health effects. This entry is data analysis only; the experiment, inputs and pipeline are not specified.

Service highlights

• Research analysis of sequence data from a defined SELEX project.
• Selection rounds, controls and target context are required to interpret enrichment.
• No patient diagnosis, health-risk prediction or treatment guidance.

Who may consider it

• Aptamer discovery research teams conducting SELEX.
• Projects with sequencing data, selection-round metadata and a defined target.

What to expect

Confirm accepted read files, target, selection-round design, controls, analysis pipeline and report format. Confirm whether experimental selection or sequencing is separate, current service availability, turnaround and quote. This listing describes data analysis only.

Scope and limitations

The scope is research analysis of SELEX sequencing data. Enrichment is not equivalent to a measured binding affinity, validated diagnostic biomarker, human genetic variant or clinical result; no diagnosis or treatment recommendation is provided.

Frequently asked questions